Dube Michael P

EDGAR CIK 0002019493

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
VP, Chief Accounting Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($95,014)
-7,494 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/02/2026
10/06/2026
Sell
-1,864 @ $12.43
 ($23,170) 65,022 (-2.79%) Direct
07/01/2026
07/06/2026
Sell
-2,641 @ $16.78
 ($44,316) 66,886 (-3.80%) Direct
01/05/2026
01/07/2026
Sell
-2,989 @ $9.21
 ($27,529) 52,277 (-5.41%) Direct